Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
25401
25402
25403
25404
25405
25406
25407
25408
25409
25410
25411
25412
25413
25414
25415
25416
25417
25418
25419
25420
25421
25422
25423
25424
25425
25426
25427
25428
25429
25430
25431
25432
25433
25434
25435
25436
25437
25438
25439
25440
25441
25442
25443
25444
25445
25446
25447
25448
25449
25450
25451
25452
25453
25454
25455
25456
25457
25458
25459
25460
25461
25462
25463
25464
25465
25466
25467
25468
25469
25470
25471
25472
25473
25474
25475
25476
25477
25478
25479
25480
25481
25482
25483
25484
25485
25486
25487
25488
25489
25490
25491
25492
25493
25494
25495
25496
25497
25498
25499
25500
25501
25502
25503
25504
25505
25506
25507
25508
25509
25510
25511
25512
25513
25514
25515
25516
25517
25518
25519
25520
25521
25522
25523
25524
25525
25526
25527
25528
25529
25530
25531
25532
25533
25534
25535
25536
25537
25538
25539
25540
25541
25542
25543
25544
25545
25546
25547
25548
25549
25550
25551
25552
25553
25554
25555
25556
25557
25558
25559
25560
25561
25562
25563
25564
25565
25566
25567
25568
25569
25570
25571
25572
25573
25574
25575
25576
25577
25578
25579
25580
25581
25582
25583
25584
25585
25586
25587
25588
25589
25590
25591
25592
25593
25594
25595
25596
25597
25598
25599
25600
| UnnamedSample_HQ_transcript/3394|m.1589 | UnnamedSample_HQ_transcript/3394 | Identity 0.583 too low. | fbd62cddb0590817763bf8af5cd55481 | 1574 | Pfam | PF00041 | Fibronectin type III domain | 1177 | 1250 | 6.9E-11 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/3394|m.1589 | UnnamedSample_HQ_transcript/3394 | Identity 0.583 too low. | fbd62cddb0590817763bf8af5cd55481 | 1574 | Pfam | PF07679 | Immunoglobulin I-set domain | 1076 | 1161 | 2.8E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/3394|m.1589 | UnnamedSample_HQ_transcript/3394 | Identity 0.583 too low. | fbd62cddb0590817763bf8af5cd55481 | 1574 | Pfam | PF07679 | Immunoglobulin I-set domain | 591 | 683 | 1.2E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/3394|m.1589 | UnnamedSample_HQ_transcript/3394 | Identity 0.583 too low. | fbd62cddb0590817763bf8af5cd55481 | 1574 | Pfam | PF07679 | Immunoglobulin I-set domain | 256 | 346 | 2.3E-17 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/3394|m.1589 | UnnamedSample_HQ_transcript/3394 | Identity 0.583 too low. | fbd62cddb0590817763bf8af5cd55481 | 1574 | Pfam | PF07679 | Immunoglobulin I-set domain | 470 | 562 | 2.0E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/3394|m.1589 | UnnamedSample_HQ_transcript/3394 | Identity 0.583 too low. | fbd62cddb0590817763bf8af5cd55481 | 1574 | Pfam | PF07679 | Immunoglobulin I-set domain | 743 | 832 | 2.7E-19 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/3394|m.1589 | UnnamedSample_HQ_transcript/3394 | Identity 0.583 too low. | fbd62cddb0590817763bf8af5cd55481 | 1574 | Pfam | PF07679 | Immunoglobulin I-set domain | 852 | 940 | 6.8E-12 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/3394|m.1589 | UnnamedSample_HQ_transcript/3394 | Identity 0.583 too low. | fbd62cddb0590817763bf8af5cd55481 | 1574 | Pfam | PF07679 | Immunoglobulin I-set domain | 138 | 226 | 8.9E-15 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/3394|m.1589 | UnnamedSample_HQ_transcript/3394 | Identity 0.583 too low. | fbd62cddb0590817763bf8af5cd55481 | 1574 | Pfam | PF07679 | Immunoglobulin I-set domain | 961 | 1045 | 3.3E-13 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/3394|m.1589 | UnnamedSample_HQ_transcript/3394 | Identity 0.583 too low. | fbd62cddb0590817763bf8af5cd55481 | 1574 | Pfam | PF07679 | Immunoglobulin I-set domain | 357 | 447 | 1.4E-15 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/3394|m.1589 | UnnamedSample_HQ_transcript/3394 | Identity 0.583 too low. | fbd62cddb0590817763bf8af5cd55481 | 1574 | Pfam | PF00069 | Protein kinase domain | 1284 | 1539 | 1.3E-70 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/115650|m.24458 | UnnamedSample_HQ_transcript/115650 | Coverage 0.986 too low. | 85029af5e7b60cb73bb076163b125e1f | 172 | Pfam | PF00213 | ATP synthase delta (OSCP) subunit | 2 | 167 | 3.1E-39 | T | 22-09-2020 | IPR000711 | ATPase, OSCP/delta subunit |
| UnnamedSample_HQ_transcript/21616|m.7314 | UnnamedSample_HQ_transcript/21616 | Coverage 0.873 too low. | cd6243b405768220e660901b63dee3e7 | 905 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 43 | 79 | 1.1E-11 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/21616|m.7314 | UnnamedSample_HQ_transcript/21616 | Coverage 0.873 too low. | cd6243b405768220e660901b63dee3e7 | 905 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 83 | 115 | 3.2E-9 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/21616|m.7314 | UnnamedSample_HQ_transcript/21616 | Coverage 0.873 too low. | cd6243b405768220e660901b63dee3e7 | 905 | Pfam | PF00089 | Trypsin | 300 | 538 | 9.9E-29 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/21616|m.7314 | UnnamedSample_HQ_transcript/21616 | Coverage 0.873 too low. | cd6243b405768220e660901b63dee3e7 | 905 | Pfam | PF00089 | Trypsin | 654 | 899 | 6.7E-43 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/89667|m.21187 | UnnamedSample_HQ_transcript/89667 | Coverage 0.288 too low. | 1d82aa87645419cb31e2bb3f7d967445 | 310 | Pfam | PF06209 | Cofactor of BRCA1 (COBRA1) | 1 | 309 | 3.9E-164 | T | 22-09-2020 | IPR010405 | Cofactor of BRCA1 |
| UnnamedSample_HQ_transcript/96326|m.22143 | UnnamedSample_HQ_transcript/96326 | Coverage 0.818 too low. | b94fe121b687c07c9dbd193b12573e83 | 403 | Pfam | PF07686 | Immunoglobulin V-set domain | 19 | 103 | 4.2E-8 | T | 22-09-2020 | IPR013106 | Immunoglobulin V-set domain |
| UnnamedSample_HQ_transcript/96326|m.22143 | UnnamedSample_HQ_transcript/96326 | Coverage 0.818 too low. | b94fe121b687c07c9dbd193b12573e83 | 403 | Pfam | PF00047 | Immunoglobulin domain | 148 | 225 | 8.2E-9 | T | 22-09-2020 | IPR013151 | Immunoglobulin |
| UnnamedSample_HQ_transcript/96326|m.22143 | UnnamedSample_HQ_transcript/96326 | Coverage 0.818 too low. | b94fe121b687c07c9dbd193b12573e83 | 403 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 245 | 324 | 7.0E-8 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/1367|m.791 | UnnamedSample_HQ_transcript/1367 | Coverage 0.943 too low. | e4578c13e35ea4596ddd52a16b37b75a | 1894 | Pfam | PF00435 | Spectrin repeat | 1343 | 1440 | 8.6E-16 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/1367|m.791 | UnnamedSample_HQ_transcript/1367 | Coverage 0.943 too low. | e4578c13e35ea4596ddd52a16b37b75a | 1894 | Pfam | PF00435 | Spectrin repeat | 911 | 1014 | 4.4E-17 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/1367|m.791 | UnnamedSample_HQ_transcript/1367 | Coverage 0.943 too low. | e4578c13e35ea4596ddd52a16b37b75a | 1894 | Pfam | PF00435 | Spectrin repeat | 805 | 906 | 1.3E-18 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/1367|m.791 | UnnamedSample_HQ_transcript/1367 | Coverage 0.943 too low. | e4578c13e35ea4596ddd52a16b37b75a | 1894 | Pfam | PF00435 | Spectrin repeat | 1127 | 1223 | 2.2E-12 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/1367|m.791 | UnnamedSample_HQ_transcript/1367 | Coverage 0.943 too low. | e4578c13e35ea4596ddd52a16b37b75a | 1894 | Pfam | PF00435 | Spectrin repeat | 1656 | 1758 | 4.3E-22 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/1367|m.791 | UnnamedSample_HQ_transcript/1367 | Coverage 0.943 too low. | e4578c13e35ea4596ddd52a16b37b75a | 1894 | Pfam | PF00435 | Spectrin repeat | 1444 | 1546 | 8.5E-21 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/1367|m.791 | UnnamedSample_HQ_transcript/1367 | Coverage 0.943 too low. | e4578c13e35ea4596ddd52a16b37b75a | 1894 | Pfam | PF00435 | Spectrin repeat | 1233 | 1333 | 1.6E-16 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/1367|m.791 | UnnamedSample_HQ_transcript/1367 | Coverage 0.943 too low. | e4578c13e35ea4596ddd52a16b37b75a | 1894 | Pfam | PF00435 | Spectrin repeat | 481 | 590 | 6.6E-14 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/1367|m.791 | UnnamedSample_HQ_transcript/1367 | Coverage 0.943 too low. | e4578c13e35ea4596ddd52a16b37b75a | 1894 | Pfam | PF00435 | Spectrin repeat | 1551 | 1653 | 6.4E-19 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/1367|m.791 | UnnamedSample_HQ_transcript/1367 | Coverage 0.943 too low. | e4578c13e35ea4596ddd52a16b37b75a | 1894 | Pfam | PF00435 | Spectrin repeat | 699 | 800 | 1.1E-22 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/1367|m.791 | UnnamedSample_HQ_transcript/1367 | Coverage 0.943 too low. | e4578c13e35ea4596ddd52a16b37b75a | 1894 | Pfam | PF00435 | Spectrin repeat | 1017 | 1123 | 5.2E-18 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/1367|m.791 | UnnamedSample_HQ_transcript/1367 | Coverage 0.943 too low. | e4578c13e35ea4596ddd52a16b37b75a | 1894 | Pfam | PF00435 | Spectrin repeat | 1763 | 1865 | 5.1E-19 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/1367|m.791 | UnnamedSample_HQ_transcript/1367 | Coverage 0.943 too low. | e4578c13e35ea4596ddd52a16b37b75a | 1894 | Pfam | PF00435 | Spectrin repeat | 256 | 364 | 2.9E-12 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/1367|m.791 | UnnamedSample_HQ_transcript/1367 | Coverage 0.943 too low. | e4578c13e35ea4596ddd52a16b37b75a | 1894 | Pfam | PF00435 | Spectrin repeat | 593 | 695 | 4.9E-25 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/1367|m.791 | UnnamedSample_HQ_transcript/1367 | Coverage 0.943 too low. | e4578c13e35ea4596ddd52a16b37b75a | 1894 | Pfam | PF00435 | Spectrin repeat | 376 | 477 | 9.7E-17 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/1367|m.791 | UnnamedSample_HQ_transcript/1367 | Coverage 0.943 too low. | e4578c13e35ea4596ddd52a16b37b75a | 1894 | Pfam | PF00307 | Calponin homology (CH) domain | 7 | 109 | 4.2E-19 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/1367|m.791 | UnnamedSample_HQ_transcript/1367 | Coverage 0.943 too low. | e4578c13e35ea4596ddd52a16b37b75a | 1894 | Pfam | PF00307 | Calponin homology (CH) domain | 126 | 230 | 2.6E-26 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/71733|m.18257 | UnnamedSample_HQ_transcript/71733 | Coverage 0.153 too low. | d05f5e07b6b1b362ae1b4c4b5a9e818b | 406 | Pfam | PF04678 | Mitochondrial calcium uniporter | 137 | 342 | 4.0E-62 | T | 22-09-2020 | IPR006769 | Calcium uniporter protein, C-terminal |
| UnnamedSample_HQ_transcript/10003|m.3830 | UnnamedSample_HQ_transcript/10003 | Coverage 0.986 too low. | aa506da0e7d8b96e6c5da7cfd6b2dffb | 908 | Pfam | PF16558 | Amino-terminal Zinc-binding domain of ubiquitin ligase E3A | 60 | 111 | 6.7E-13 | T | 22-09-2020 | IPR032353 | Ubiquitin-protein ligase E3A, N-terminal zinc-binding domain |
| UnnamedSample_HQ_transcript/10003|m.3830 | UnnamedSample_HQ_transcript/10003 | Coverage 0.986 too low. | aa506da0e7d8b96e6c5da7cfd6b2dffb | 908 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 609 | 907 | 9.4E-88 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/16862|m.5960 | UnnamedSample_HQ_transcript/16862 | Coverage 0.986 too low. | aa506da0e7d8b96e6c5da7cfd6b2dffb | 908 | Pfam | PF16558 | Amino-terminal Zinc-binding domain of ubiquitin ligase E3A | 60 | 111 | 6.7E-13 | T | 22-09-2020 | IPR032353 | Ubiquitin-protein ligase E3A, N-terminal zinc-binding domain |
| UnnamedSample_HQ_transcript/16862|m.5960 | UnnamedSample_HQ_transcript/16862 | Coverage 0.986 too low. | aa506da0e7d8b96e6c5da7cfd6b2dffb | 908 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 609 | 907 | 9.4E-88 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/4544|m.2016 | UnnamedSample_HQ_transcript/4544 | Coverage 0.150 too low. | c5aae0d93f026ce9d7d9fa7348544ea5 | 1548 | Pfam | PF00307 | Calponin homology (CH) domain | 313 | 415 | 1.5E-16 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/4544|m.2016 | UnnamedSample_HQ_transcript/4544 | Coverage 0.150 too low. | c5aae0d93f026ce9d7d9fa7348544ea5 | 1548 | Pfam | PF00307 | Calponin homology (CH) domain | 170 | 276 | 3.6E-21 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/4544|m.2016 | UnnamedSample_HQ_transcript/4544 | Coverage 0.150 too low. | c5aae0d93f026ce9d7d9fa7348544ea5 | 1548 | Pfam | PF00435 | Spectrin repeat | 937 | 1035 | 1.0E-6 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/66631|m.17343 | UnnamedSample_HQ_transcript/66631 | Coverage 0.774 too low. | 5d412be7b094baf67b0e1c5863322496 | 463 | Pfam | PF00083 | Sugar (and other) transporter | 59 | 459 | 1.0E-49 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/63796|m.16797 | UnnamedSample_HQ_transcript/63796 | Identity 0.290 too low. | 5d412be7b094baf67b0e1c5863322496 | 463 | Pfam | PF00083 | Sugar (and other) transporter | 59 | 459 | 1.0E-49 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/93128|m.21683 | UnnamedSample_HQ_transcript/93128 | Coverage 0.947 too low. | 028e78f9664d4477775cca9ca18fdf9b | 234 | Pfam | PF02738 | Molybdopterin-binding domain of aldehyde dehydrogenase | 14 | 154 | 8.2E-33 | T | 22-09-2020 | IPR008274 | Aldehyde oxidase/xanthine dehydrogenase, molybdopterin binding |
| UnnamedSample_HQ_transcript/81290|m.19930 | UnnamedSample_HQ_transcript/81290 | Coverage 0.566 too low. | d1b59f4a09db042dd2aad6129d825099 | 147 | Pfam | PF00628 | PHD-finger | 87 | 134 | 3.3E-10 | T | 22-09-2020 | IPR019787 | Zinc finger, PHD-finger |
| UnnamedSample_HQ_transcript/1202|m.722 | UnnamedSample_HQ_transcript/1202 | Identity 0.864 too low. | 718371a0f6e785f4d4b0d95fb49df0e7 | 397 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 17 | 74 | 2.9E-15 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/1202|m.722 | UnnamedSample_HQ_transcript/1202 | Identity 0.864 too low. | 718371a0f6e785f4d4b0d95fb49df0e7 | 397 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 107 | 164 | 1.0E-15 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/94593|m.21890 | UnnamedSample_HQ_transcript/94593 | Coverage 0.142 too low. | 6f050bb782c82444476697e8a03f31c9 | 215 | Pfam | PF10197 | N-terminal domain of CBF1 interacting co-repressor CIR | 14 | 49 | 3.1E-12 | T | 22-09-2020 | IPR019339 | CBF1-interacting co-repressor CIR, N-terminal domain |
| UnnamedSample_HQ_transcript/100563|m.22713 | UnnamedSample_HQ_transcript/100563 | Coverage 0.988 too low. | dd5a700fc74fdbdad2f2cf51fbfd0ff9 | 280 | Pfam | PF05653 | Magnesium transporter NIPA | 1 | 237 | 3.8E-99 | T | 22-09-2020 | IPR008521 | Magnesium transporter NIPA |
| UnnamedSample_HQ_transcript/98720|m.22457 | UnnamedSample_HQ_transcript/98720 | Identity 0.895 too low. | 5aad8d4a84e1be6ca0cf447da023fd30 | 260 | Pfam | PF01496 | V-type ATPase 116kDa subunit family | 1 | 248 | 9.4E-91 | T | 22-09-2020 | IPR002490 | V-type ATPase, V0 complex, 116kDa subunit family |
| UnnamedSample_HQ_transcript/90576|m.21339 | UnnamedSample_HQ_transcript/90576 | Coverage 0.858 too low. | 8c0bba7193507271762172aaf178ffcd | 426 | Pfam | PF00992 | Troponin | 152 | 228 | 5.5E-10 | T | 22-09-2020 | IPR001978 | Troponin |
| UnnamedSample_HQ_transcript/100492|m.22708 | UnnamedSample_HQ_transcript/100492 | Coverage 0.103 too low. | bd011aa9bfa7997354d9fa9987dd3c39 | 211 | Pfam | PF01244 | Membrane dipeptidase (Peptidase family M19) | 1 | 209 | 7.9E-60 | T | 22-09-2020 | IPR008257 | Peptidase M19 |
| UnnamedSample_HQ_transcript/7803|m.3123 | UnnamedSample_HQ_transcript/7803 | Coverage 0.948 too low. | 291d2ec4f79898e530bb9985366ee922 | 566 | Pfam | PF16898 | C-terminal associated domain of TOPRIM | 22 | 122 | 4.8E-28 | T | 22-09-2020 | IPR031660 | C-terminal associated domain of TOPRIM |
| UnnamedSample_HQ_transcript/7803|m.3123 | UnnamedSample_HQ_transcript/7803 | Coverage 0.948 too low. | 291d2ec4f79898e530bb9985366ee922 | 566 | Pfam | PF00521 | DNA gyrase/topoisomerase IV, subunit A | 124 | 565 | 2.5E-120 | T | 22-09-2020 | IPR002205 | DNA topoisomerase, type IIA, subunit A/C-terminal |
| UnnamedSample_HQ_transcript/65594|m.17130 | UnnamedSample_HQ_transcript/65594 | Coverage 0.935 too low. | 291d2ec4f79898e530bb9985366ee922 | 566 | Pfam | PF16898 | C-terminal associated domain of TOPRIM | 22 | 122 | 4.8E-28 | T | 22-09-2020 | IPR031660 | C-terminal associated domain of TOPRIM |
| UnnamedSample_HQ_transcript/65594|m.17130 | UnnamedSample_HQ_transcript/65594 | Coverage 0.935 too low. | 291d2ec4f79898e530bb9985366ee922 | 566 | Pfam | PF00521 | DNA gyrase/topoisomerase IV, subunit A | 124 | 565 | 2.5E-120 | T | 22-09-2020 | IPR002205 | DNA topoisomerase, type IIA, subunit A/C-terminal |
| UnnamedSample_HQ_transcript/74704|m.18778 | UnnamedSample_HQ_transcript/74704 | Identity 0.943 too low. | a1f6e1c796eeedda6c8c8c75c2954e12 | 402 | Pfam | PF10516 | SHNi-TPR | 314 | 346 | 4.2E-7 | T | 22-09-2020 | IPR019544 | Tetratricopeptide, SHNi-TPR domain |
| UnnamedSample_HQ_transcript/17324|m.6098 | UnnamedSample_HQ_transcript/17324 | Coverage 0.989 too low. | 96a89f226b94b88a5f06d945798f14f0 | 1004 | Pfam | PF00651 | BTB/POZ domain | 314 | 432 | 6.1E-13 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/17324|m.6098 | UnnamedSample_HQ_transcript/17324 | Coverage 0.989 too low. | 96a89f226b94b88a5f06d945798f14f0 | 1004 | Pfam | PF00651 | BTB/POZ domain | 26 | 113 | 8.1E-10 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/18446|m.6431 | UnnamedSample_HQ_transcript/18446 | Coverage 0.988 too low. | 96a89f226b94b88a5f06d945798f14f0 | 1004 | Pfam | PF00651 | BTB/POZ domain | 314 | 432 | 6.1E-13 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/18446|m.6431 | UnnamedSample_HQ_transcript/18446 | Coverage 0.988 too low. | 96a89f226b94b88a5f06d945798f14f0 | 1004 | Pfam | PF00651 | BTB/POZ domain | 26 | 113 | 8.1E-10 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/121648|m.24970 | UnnamedSample_HQ_transcript/121648 | Coverage 0.978 too low. | ac6864fd089b89e0b0f953714fb3647d | 131 | Pfam | PF04676 | Protein similar to CwfJ C-terminus 2 | 38 | 129 | 1.1E-25 | T | 22-09-2020 | IPR006767 | Cwf19-like protein, C-terminal domain-2 |
| UnnamedSample_HQ_transcript/5554|m.2374 | UnnamedSample_HQ_transcript/5554 | Identity 0.788 too low. | 3b4ab8daba51a329044597640cf28d4b | 1357 | Pfam | PF01171 | PP-loop family | 1130 | 1296 | 2.3E-12 | T | 22-09-2020 | IPR011063 | tRNA(Ile)-lysidine/2-thiocytidine synthase, N-terminal |
| UnnamedSample_HQ_transcript/5554|m.2374 | UnnamedSample_HQ_transcript/5554 | Identity 0.788 too low. | 3b4ab8daba51a329044597640cf28d4b | 1357 | Pfam | PF00266 | Aminotransferase class-V | 67 | 435 | 6.3E-26 | T | 22-09-2020 | IPR000192 | Aminotransferase class V domain |
| UnnamedSample_HQ_transcript/6333|m.2648 | UnnamedSample_HQ_transcript/6333 | Identity 0.769 too low. | 3b4ab8daba51a329044597640cf28d4b | 1357 | Pfam | PF01171 | PP-loop family | 1130 | 1296 | 2.3E-12 | T | 22-09-2020 | IPR011063 | tRNA(Ile)-lysidine/2-thiocytidine synthase, N-terminal |
| UnnamedSample_HQ_transcript/6333|m.2648 | UnnamedSample_HQ_transcript/6333 | Identity 0.769 too low. | 3b4ab8daba51a329044597640cf28d4b | 1357 | Pfam | PF00266 | Aminotransferase class-V | 67 | 435 | 6.3E-26 | T | 22-09-2020 | IPR000192 | Aminotransferase class V domain |
| UnnamedSample_HQ_transcript/14034|m.5118 | UnnamedSample_HQ_transcript/14034 | Identity 0.580 too low. | 0f47cca911c996a9e8d109f92aeb54b2 | 395 | Pfam | PF00069 | Protein kinase domain | 25 | 289 | 7.4E-62 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/51273|m.14299 | UnnamedSample_HQ_transcript/51273 | Coverage 0.244 too low. | 4dd149f61fb64f743505152b2f343647 | 232 | Pfam | PF00028 | Cadherin domain | 112 | 205 | 1.0E-15 | T | 22-09-2020 | IPR002126 | Cadherin-like |
| UnnamedSample_HQ_transcript/50955|m.14240 | UnnamedSample_HQ_transcript/50955 | Coverage 0.379 too low. | ab5340e4b3c1368c47c31ac4ef2c71a8 | 188 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 115 | 184 | 4.2E-32 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/62755|m.16587 | UnnamedSample_HQ_transcript/62755 | Identity 0.413 too low. | a4c76d528ffebe574ab8760b5ba3b5a3 | 551 | Pfam | PF02207 | Putative zinc finger in N-recognin (UBR box) | 2 | 49 | 1.6E-7 | T | 22-09-2020 | IPR003126 | Zinc finger, UBR-type |
| UnnamedSample_HQ_transcript/25729|m.8403 | UnnamedSample_HQ_transcript/25729 | Identity 0.655 too low. | 76de265f3f44c0d6ce96bf44d7b890d4 | 779 | Pfam | PF12432 | Protein of unknown function (DUF3677) | 100 | 180 | 2.1E-20 | T | 22-09-2020 | IPR022145 | Domain of unknown function DUF3677 |
| UnnamedSample_HQ_transcript/20919|m.7127 | UnnamedSample_HQ_transcript/20919 | Coverage 0.797 too low. | 3c478cb0f633c497c88ba79eac2081c9 | 898 | Pfam | PF00096 | Zinc finger, C2H2 type | 779 | 801 | 0.0011 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/10947|m.4133 | UnnamedSample_HQ_transcript/10947 | Coverage 0.651 too low. | 3c478cb0f633c497c88ba79eac2081c9 | 898 | Pfam | PF00096 | Zinc finger, C2H2 type | 779 | 801 | 0.0011 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/56477|m.15334 | UnnamedSample_HQ_transcript/56477 | Unmapped. | 6d3526b4cdd7035fb908bd587a32a1cb | 506 | Pfam | PF13604 | AAA domain | 209 | 368 | 1.9E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/56477|m.15334 | UnnamedSample_HQ_transcript/56477 | Unmapped. | 6d3526b4cdd7035fb908bd587a32a1cb | 506 | Pfam | PF13087 | AAA domain | 389 | 493 | 9.9E-9 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/1064|m.661 | UnnamedSample_HQ_transcript/1064 | Coverage 0.023 too low. | 774ecbee8f8ae2527ce7b3206e6196a7 | 1986 | Pfam | PF16197 | Ketoacyl-synthetase C-terminal extension | 235 | 345 | 3.5E-33 | T | 22-09-2020 | IPR032821 | Polyketide synthase, C-terminal extension |
| UnnamedSample_HQ_transcript/1064|m.661 | UnnamedSample_HQ_transcript/1064 | Coverage 0.023 too low. | 774ecbee8f8ae2527ce7b3206e6196a7 | 1986 | Pfam | PF02801 | Beta-ketoacyl synthase, C-terminal domain | 105 | 232 | 4.7E-28 | T | 22-09-2020 | IPR014031 | Beta-ketoacyl synthase, C-terminal |
| UnnamedSample_HQ_transcript/1064|m.661 | UnnamedSample_HQ_transcript/1064 | Coverage 0.023 too low. | 774ecbee8f8ae2527ce7b3206e6196a7 | 1986 | Pfam | PF00109 | Beta-ketoacyl synthase, N-terminal domain | 1 | 101 | 2.5E-25 | T | 22-09-2020 | IPR014030 | Beta-ketoacyl synthase, N-terminal |
| UnnamedSample_HQ_transcript/1064|m.661 | UnnamedSample_HQ_transcript/1064 | Coverage 0.023 too low. | 774ecbee8f8ae2527ce7b3206e6196a7 | 1986 | Pfam | PF00698 | Acyl transferase domain | 369 | 682 | 2.5E-68 | T | 22-09-2020 | IPR014043 | Acyl transferase |
| UnnamedSample_HQ_transcript/1064|m.661 | UnnamedSample_HQ_transcript/1064 | Coverage 0.023 too low. | 774ecbee8f8ae2527ce7b3206e6196a7 | 1986 | Pfam | PF08659 | KR domain | 1682 | 1860 | 1.4E-27 | T | 22-09-2020 | IPR013968 | Polyketide synthase, ketoreductase domain |
| UnnamedSample_HQ_transcript/59438|m.15933 | UnnamedSample_HQ_transcript/59438 | Identity 0.911 too low. | eff6467c155d09d0e8fc15299abe2527 | 190 | Pfam | PF14604 | Variant SH3 domain | 5 | 56 | 7.4E-13 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/113236|m.24210 | UnnamedSample_HQ_transcript/113236 | Coverage 0.986 too low. | d76a41b296a7fcbbb5365c76b2e57439 | 172 | Pfam | PF08617 | Kinase binding protein CGI-121 | 17 | 170 | 8.1E-27 | T | 22-09-2020 | IPR013926 | CGI121/TPRKB |
| UnnamedSample_HQ_transcript/15390|m.5519 | UnnamedSample_HQ_transcript/15390 | Coverage 0.044 too low. | 726a0ef5d81b6c815ffb52731309dd2d | 1143 | Pfam | PF14910 | S-phase genomic integrity recombination mediator, N-terminal | 1 | 642 | 1.0E-69 | T | 22-09-2020 | IPR029425 | Protein MMS22-like, N-terminal |
| UnnamedSample_HQ_transcript/15390|m.5519 | UnnamedSample_HQ_transcript/15390 | Coverage 0.044 too low. | 726a0ef5d81b6c815ffb52731309dd2d | 1143 | Pfam | PF14911 | S-phase genomic integrity recombination mediator, C-terminal | 761 | 1133 | 1.4E-69 | T | 22-09-2020 | IPR029424 | MMS22-like, C-terminal |
| UnnamedSample_HQ_transcript/46750|m.13310 | UnnamedSample_HQ_transcript/46750 | Coverage 0.958 too low. | f74524ab74be62288739b4b1e11ba59d | 747 | Pfam | PF01576 | Myosin tail | 2 | 742 | 2.0E-111 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/17297|m.6091 | UnnamedSample_HQ_transcript/17297 | Coverage 0.088 too low. | dc4ccf14b3d1d08ae5dcf7884ab5ccbb | 969 | Pfam | PF15898 | cGMP-dependent protein kinase interacting domain | 869 | 969 | 9.1E-33 | T | 22-09-2020 | IPR031775 | cGMP-dependent protein kinase, interacting domain |
| UnnamedSample_HQ_transcript/17297|m.6091 | UnnamedSample_HQ_transcript/17297 | Coverage 0.088 too low. | dc4ccf14b3d1d08ae5dcf7884ab5ccbb | 969 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 51 | 138 | 8.9E-17 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/17297|m.6091 | UnnamedSample_HQ_transcript/17297 | Coverage 0.088 too low. | dc4ccf14b3d1d08ae5dcf7884ab5ccbb | 969 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 197 | 266 | 1.4E-12 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/81709|m.19984 | UnnamedSample_HQ_transcript/81709 | Identity 0.945 too low. | 0e94630afd1bf75302376615b52d7126 | 222 | Pfam | PF00145 | C-5 cytosine-specific DNA methylase | 134 | 205 | 4.8E-16 | T | 22-09-2020 | IPR001525 | C-5 cytosine methyltransferase |
| UnnamedSample_HQ_transcript/41896|m.12243 | UnnamedSample_HQ_transcript/41896 | Coverage 0.476 too low. | 52f4e437dd021f09cbc7ac1a52f8727b | 350 | Pfam | PF00620 | RhoGAP domain | 14 | 64 | 9.0E-10 | T | 22-09-2020 | IPR000198 | Rho GTPase-activating protein domain |
| UnnamedSample_HQ_transcript/54483|m.14937 | UnnamedSample_HQ_transcript/54483 | Coverage 0.822 too low. | bb1effa05b9ad883b9f244f2bf9b7cf1 | 562 | Pfam | PF00135 | Carboxylesterase family | 23 | 542 | 2.5E-135 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/66019|m.17217 | UnnamedSample_HQ_transcript/66019 | Coverage 0.893 too low. | bb1effa05b9ad883b9f244f2bf9b7cf1 | 562 | Pfam | PF00135 | Carboxylesterase family | 23 | 542 | 2.5E-135 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/48017|m.13582 | UnnamedSample_HQ_transcript/48017 | Coverage 0.769 too low. | bb1effa05b9ad883b9f244f2bf9b7cf1 | 562 | Pfam | PF00135 | Carboxylesterase family | 23 | 542 | 2.5E-135 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/69536|m.17849 | UnnamedSample_HQ_transcript/69536 | Identity 0.926 too low. | eca01b811a545d1390c6c8dad057bdc5 | 224 | Pfam | PF01661 | Macro domain | 94 | 203 | 1.1E-4 | T | 22-09-2020 | IPR002589 | Macro domain |
| UnnamedSample_HQ_transcript/80721|m.19829 | UnnamedSample_HQ_transcript/80721 | Identity 0.526 too low. | b5fbf10876f59d917ea688b2921aaa93 | 440 | Pfam | PF12146 | Serine aminopeptidase, S33 | 130 | 253 | 5.5E-7 | T | 22-09-2020 | IPR022742 | Serine aminopeptidase, S33 |
| UnnamedSample_HQ_transcript/80721|m.19829 | UnnamedSample_HQ_transcript/80721 | Identity 0.526 too low. | b5fbf10876f59d917ea688b2921aaa93 | 440 | Pfam | PF04083 | Partial alpha/beta-hydrolase lipase region | 70 | 128 | 8.3E-19 | T | 22-09-2020 | IPR006693 | Partial AB-hydrolase lipase domain |
| UnnamedSample_HQ_transcript/37|m.38 | UnnamedSample_HQ_transcript/37 | Coverage 0.316 too low. | 765e768abcd339c0b468e57eaead5027 | 2965 | Pfam | PF11547 | E3 ubiquitin ligase EDD | 163 | 214 | 4.8E-30 | T | 22-09-2020 | IPR024725 | E3 ubiquitin ligase EDD, ubiquitin-associated domain |
| UnnamedSample_HQ_transcript/37|m.38 | UnnamedSample_HQ_transcript/37 | Coverage 0.316 too low. | 765e768abcd339c0b468e57eaead5027 | 2965 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 2834 | 2960 | 4.7E-17 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/37|m.38 | UnnamedSample_HQ_transcript/37 | Coverage 0.316 too low. | 765e768abcd339c0b468e57eaead5027 | 2965 | Pfam | PF00658 | Poly-adenylate binding protein, unique domain | 2730 | 2787 | 5.3E-22 | T | 22-09-2020 | IPR002004 | Polyadenylate-binding protein/Hyperplastic disc protein |
| UnnamedSample_HQ_transcript/64775|m.16997 | UnnamedSample_HQ_transcript/64775 | Identity 0.715 too low. | 1555be526b61364424a97dccac50f16d | 415 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 162 | 249 | 5.9E-10 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/64775|m.16997 | UnnamedSample_HQ_transcript/64775 | Identity 0.715 too low. | 1555be526b61364424a97dccac50f16d | 415 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 284 | 369 | 1.5E-10 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/58933|m.15839 | UnnamedSample_HQ_transcript/58933 | Identity 0.730 too low. | 1555be526b61364424a97dccac50f16d | 415 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 162 | 249 | 5.9E-10 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/58933|m.15839 | UnnamedSample_HQ_transcript/58933 | Identity 0.730 too low. | 1555be526b61364424a97dccac50f16d | 415 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 284 | 369 | 1.5E-10 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/77622|m.19311 | UnnamedSample_HQ_transcript/77622 | Identity 0.672 too low. | 1555be526b61364424a97dccac50f16d | 415 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 162 | 249 | 5.9E-10 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/77622|m.19311 | UnnamedSample_HQ_transcript/77622 | Identity 0.672 too low. | 1555be526b61364424a97dccac50f16d | 415 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 284 | 369 | 1.5E-10 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/55197|m.15075 | UnnamedSample_HQ_transcript/55197 | Identity 0.745 too low. | 1555be526b61364424a97dccac50f16d | 415 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 162 | 249 | 5.9E-10 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/55197|m.15075 | UnnamedSample_HQ_transcript/55197 | Identity 0.745 too low. | 1555be526b61364424a97dccac50f16d | 415 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 284 | 369 | 1.5E-10 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/77911|m.19359 | UnnamedSample_HQ_transcript/77911 | Coverage 0.850 too low. | 1555be526b61364424a97dccac50f16d | 415 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 162 | 249 | 5.9E-10 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/77911|m.19359 | UnnamedSample_HQ_transcript/77911 | Coverage 0.850 too low. | 1555be526b61364424a97dccac50f16d | 415 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 284 | 369 | 1.5E-10 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/104182|m.23131 | UnnamedSample_HQ_transcript/104182 | Coverage 0.078 too low. | a3d3d3ed44348eb13e292f09041a9101 | 341 | Pfam | PF14529 | Endonuclease-reverse transcriptase | 12 | 126 | 4.8E-15 | T | 22-09-2020 | IPR005135 | Endonuclease/exonuclease/phosphatase |
| UnnamedSample_HQ_transcript/95336|m.22005 | UnnamedSample_HQ_transcript/95336 | Unmapped. | 089290cbfa70a08c6fff2bdc48e78de4 | 387 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 23 | 385 | 3.2E-54 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/77946|m.19362 | UnnamedSample_HQ_transcript/77946 | Unmapped. | 089290cbfa70a08c6fff2bdc48e78de4 | 387 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 23 | 385 | 3.2E-54 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/38204|m.11441 | UnnamedSample_HQ_transcript/38204 | Unmapped. | 089290cbfa70a08c6fff2bdc48e78de4 | 387 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 23 | 385 | 3.2E-54 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/71776|m.18269 | UnnamedSample_HQ_transcript/71776 | Unmapped. | 089290cbfa70a08c6fff2bdc48e78de4 | 387 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 23 | 385 | 3.2E-54 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/82606|m.20136 | UnnamedSample_HQ_transcript/82606 | Unmapped. | 089290cbfa70a08c6fff2bdc48e78de4 | 387 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 23 | 385 | 3.2E-54 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/90401|m.21314 | UnnamedSample_HQ_transcript/90401 | Unmapped. | 089290cbfa70a08c6fff2bdc48e78de4 | 387 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 23 | 385 | 3.2E-54 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/72060|m.18312 | UnnamedSample_HQ_transcript/72060 | Coverage 0.913 too low. | 46ee0cbeaa607f388734dcf90453fd36 | 484 | Pfam | PF00083 | Sugar (and other) transporter | 22 | 484 | 1.5E-49 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/64096|m.16863 | UnnamedSample_HQ_transcript/64096 | Coverage 0.849 too low. | 46ee0cbeaa607f388734dcf90453fd36 | 484 | Pfam | PF00083 | Sugar (and other) transporter | 22 | 484 | 1.5E-49 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/79899|m.19693 | UnnamedSample_HQ_transcript/79899 | Coverage 0.700 too low. | 270269084211f352e6d4b9840d425075 | 420 | Pfam | PF04146 | YT521-B-like domain | 138 | 273 | 2.0E-41 | T | 22-09-2020 | IPR007275 | YTH domain |
| UnnamedSample_HQ_transcript/12059|m.4512 | UnnamedSample_HQ_transcript/12059 | Coverage 0.605 too low. | 7e97d011f293cdeb33e70941a6eaa55b | 235 | Pfam | PF08235 | LNS2 (Lipin/Ned1/Smp2) | 2 | 204 | 2.7E-92 | T | 22-09-2020 | IPR013209 | Lipin/Ned1/Smp2 (LNS2) |
| UnnamedSample_HQ_transcript/70229|m.17963 | UnnamedSample_HQ_transcript/70229 | Coverage 0.834 too low. | 5893f0f11dda923fff85ff0fc7e1d3f8 | 328 | Pfam | PF00017 | SH2 domain | 164 | 245 | 5.6E-9 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/85985|m.20648 | UnnamedSample_HQ_transcript/85985 | Coverage 0.797 too low. | 5893f0f11dda923fff85ff0fc7e1d3f8 | 328 | Pfam | PF00017 | SH2 domain | 164 | 245 | 5.6E-9 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/66924|m.17393 | UnnamedSample_HQ_transcript/66924 | Coverage 0.880 too low. | 5893f0f11dda923fff85ff0fc7e1d3f8 | 328 | Pfam | PF00017 | SH2 domain | 164 | 245 | 5.6E-9 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/62650|m.16567 | UnnamedSample_HQ_transcript/62650 | Coverage 0.924 too low. | 5893f0f11dda923fff85ff0fc7e1d3f8 | 328 | Pfam | PF00017 | SH2 domain | 164 | 245 | 5.6E-9 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/22987|m.7685 | UnnamedSample_HQ_transcript/22987 | Coverage 0.915 too low. | 5c67722144eefa1e0e94b4b1fc0dcf3d | 993 | Pfam | PF00595 | PDZ domain | 9 | 84 | 3.5E-5 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/73520|m.18572 | UnnamedSample_HQ_transcript/73520 | Coverage 0.781 too low. | 062e051dc4cbe5530b8935f07336b789 | 424 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.4E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/12106|m.4527 | UnnamedSample_HQ_transcript/12106 | Coverage 0.939 too low. | c875eb5cacad2c604e5cdce36c347d77 | 588 | Pfam | PF07690 | Major Facilitator Superfamily | 373 | 542 | 1.9E-11 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/74763|m.18788 | UnnamedSample_HQ_transcript/74763 | Identity 0.708 too low. | a25546a4ccfd03c2cc2d823575b406a5 | 427 | Pfam | PF03723 | Hemocyanin, ig-like domain | 118 | 373 | 1.1E-82 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/74763|m.18788 | UnnamedSample_HQ_transcript/74763 | Identity 0.708 too low. | a25546a4ccfd03c2cc2d823575b406a5 | 427 | Pfam | PF00372 | Hemocyanin, copper containing domain | 5 | 109 | 1.3E-25 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/8724|m.3425 | UnnamedSample_HQ_transcript/8724 | Coverage 0.990 too low. | c6a76c06caa9048bc1c6548e002d459a | 1253 | Pfam | PF07679 | Immunoglobulin I-set domain | 663 | 741 | 1.4E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/8724|m.3425 | UnnamedSample_HQ_transcript/8724 | Coverage 0.990 too low. | c6a76c06caa9048bc1c6548e002d459a | 1253 | Pfam | PF00047 | Immunoglobulin domain | 31 | 102 | 9.6E-5 | T | 22-09-2020 | IPR013151 | Immunoglobulin |
| UnnamedSample_HQ_transcript/8724|m.3425 | UnnamedSample_HQ_transcript/8724 | Coverage 0.990 too low. | c6a76c06caa9048bc1c6548e002d459a | 1253 | Pfam | PF00047 | Immunoglobulin domain | 217 | 302 | 3.2E-6 | T | 22-09-2020 | IPR013151 | Immunoglobulin |
| UnnamedSample_HQ_transcript/8724|m.3425 | UnnamedSample_HQ_transcript/8724 | Coverage 0.990 too low. | c6a76c06caa9048bc1c6548e002d459a | 1253 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 826 | 1164 | 6.1E-87 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/89374|m.21141 | UnnamedSample_HQ_transcript/89374 | Coverage 0.990 too low. | 4066905bb07e6c7b69501039d36ac251 | 390 | Pfam | PF16050 | Paf1 complex subunit CDC73 N-terminal | 1 | 291 | 7.4E-137 | T | 22-09-2020 | IPR032041 | Paf1 complex subunit Cdc73, N-terminal domain |
| UnnamedSample_HQ_transcript/66036|m.17219 | UnnamedSample_HQ_transcript/66036 | Coverage 0.287 too low. | 72470731a711f0c4961b301872ec0512 | 331 | Pfam | PF02142 | MGS-like domain | 2 | 70 | 1.9E-6 | T | 22-09-2020 | IPR011607 | Methylglyoxal synthase-like domain |
| UnnamedSample_HQ_transcript/66036|m.17219 | UnnamedSample_HQ_transcript/66036 | Coverage 0.287 too low. | 72470731a711f0c4961b301872ec0512 | 331 | Pfam | PF01808 | AICARFT/IMPCHase bienzyme | 76 | 330 | 2.6E-68 | T | 22-09-2020 | IPR002695 | Bifunctional purine biosynthesis protein PurH-like |
| UnnamedSample_HQ_transcript/20064|m.6889 | UnnamedSample_HQ_transcript/20064 | Coverage 0.128 too low. | 9e3966904ebd86ac9cccb91220061d4a | 573 | Pfam | PF02145 | Rap/ran-GAP | 299 | 479 | 3.7E-70 | T | 22-09-2020 | IPR000331 | Rap GTPase activating protein domain |
| UnnamedSample_HQ_transcript/20064|m.6889 | UnnamedSample_HQ_transcript/20064 | Coverage 0.128 too low. | 9e3966904ebd86ac9cccb91220061d4a | 573 | Pfam | PF02188 | GoLoco motif | 54 | 74 | 2.8E-8 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/54265|m.14888 | UnnamedSample_HQ_transcript/54265 | Identity 0.945 too low. | 281f66729adf5ddc98018073bb3d26f2 | 573 | Pfam | PF13087 | AAA domain | 329 | 524 | 5.7E-58 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/54265|m.14888 | UnnamedSample_HQ_transcript/54265 | Identity 0.945 too low. | 281f66729adf5ddc98018073bb3d26f2 | 573 | Pfam | PF04851 | Type III restriction enzyme, res subunit | 131 | 190 | 6.3E-6 | T | 22-09-2020 | IPR006935 | Helicase/UvrB, N-terminal |
| UnnamedSample_HQ_transcript/54265|m.14888 | UnnamedSample_HQ_transcript/54265 | Identity 0.945 too low. | 281f66729adf5ddc98018073bb3d26f2 | 573 | Pfam | PF13086 | AAA domain | 218 | 318 | 1.1E-26 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/54265|m.14888 | UnnamedSample_HQ_transcript/54265 | Identity 0.945 too low. | 281f66729adf5ddc98018073bb3d26f2 | 573 | Pfam | PF18141 | Domain of unknown function (DUF5599) | 1 | 61 | 2.2E-16 | T | 22-09-2020 | IPR040812 | Domain of unknown function DUF5599 |
| UnnamedSample_HQ_transcript/117258|m.24615 | UnnamedSample_HQ_transcript/117258 | Coverage 0.989 too low. | 3fb15f591fc01e98f2341dcdc6d4f2fb | 170 | Pfam | PF00248 | Aldo/keto reductase family | 1 | 147 | 7.5E-24 | T | 22-09-2020 | IPR023210 | NADP-dependent oxidoreductase domain |
| UnnamedSample_HQ_transcript/28019|m.8975 | UnnamedSample_HQ_transcript/28019 | Coverage 0.976 too low. | 8704393dfadcb0af8a914c384cc8c33e | 779 | Pfam | PF16013 | Domain of unknown function (DUF4781) | 8 | 180 | 2.2E-18 | T | 22-09-2020 | IPR031962 | Domain of unknown function DUF4781 |
| UnnamedSample_HQ_transcript/56504|m.15340 | UnnamedSample_HQ_transcript/56504 | Identity 0.806 too low. | 8a7f2f86e9cc6a0e63ec31e74a67033d | 465 | Pfam | PF02958 | Ecdysteroid kinase | 96 | 365 | 7.7E-52 | T | 22-09-2020 | IPR004119 | Ecdysteroid kinase-like |
| UnnamedSample_HQ_transcript/79449|m.19618 | UnnamedSample_HQ_transcript/79449 | Unmapped. | d1bd3034cf194cb74c0aa8dcde9b4ca8 | 506 | Pfam | PF00012 | Hsp70 protein | 1 | 480 | 1.8E-204 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/4802|m.2116 | UnnamedSample_HQ_transcript/4802 | Coverage 0.118 too low. | 2907c46309ab4cf022c314d56487653e | 256 | Pfam | PF12448 | Kinesin associated protein | 56 | 201 | 8.7E-21 | T | 22-09-2020 | IPR022154 | Trafficking kinesin-binding protein, C-terminal |
| UnnamedSample_HQ_transcript/21793|m.7369 | UnnamedSample_HQ_transcript/21793 | Coverage 0.842 too low. | 0642609e01ce221cb7d9c23fe78c1891 | 984 | Pfam | PF02736 | Myosin N-terminal SH3-like domain | 36 | 75 | 2.4E-12 | T | 22-09-2020 | IPR004009 | Myosin, N-terminal, SH3-like |
| UnnamedSample_HQ_transcript/21793|m.7369 | UnnamedSample_HQ_transcript/21793 | Coverage 0.842 too low. | 0642609e01ce221cb7d9c23fe78c1891 | 984 | Pfam | PF01576 | Myosin tail | 664 | 963 | 2.3E-40 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/21793|m.7369 | UnnamedSample_HQ_transcript/21793 | Coverage 0.842 too low. | 0642609e01ce221cb7d9c23fe78c1891 | 984 | Pfam | PF00063 | Myosin head (motor domain) | 416 | 584 | 5.9E-53 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/21793|m.7369 | UnnamedSample_HQ_transcript/21793 | Coverage 0.842 too low. | 0642609e01ce221cb7d9c23fe78c1891 | 984 | Pfam | PF00063 | Myosin head (motor domain) | 90 | 414 | 4.5E-134 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/82795|m.20159 | UnnamedSample_HQ_transcript/82795 | Coverage 0.949 too low. | f622d6af039dd6b419c3ed27f664a157 | 323 | Pfam | PF01370 | NAD dependent epimerase/dehydratase family | 11 | 239 | 4.7E-56 | T | 22-09-2020 | IPR001509 | NAD-dependent epimerase/dehydratase |
| UnnamedSample_HQ_transcript/113452|m.24236 | UnnamedSample_HQ_transcript/113452 | Coverage 0.911 too low. | 1ef22e390135ecd448cebb0c7c4caed5 | 148 | Pfam | PF01026 | TatD related DNase | 2 | 144 | 1.5E-21 | T | 22-09-2020 | IPR001130 | TatD family |
| UnnamedSample_HQ_transcript/43676|m.12635 | UnnamedSample_HQ_transcript/43676 | Coverage 0.849 too low. | dc8a15e6a02deef955419c9ea64a548f | 415 | Pfam | PF00069 | Protein kinase domain | 242 | 367 | 2.1E-10 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/61251|m.16317 | UnnamedSample_HQ_transcript/61251 | Coverage 0.989 too low. | d546926cc53c2d67262c894f5a86289a | 444 | Pfam | PF00439 | Bromodomain | 230 | 312 | 8.1E-19 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/61251|m.16317 | UnnamedSample_HQ_transcript/61251 | Coverage 0.989 too low. | d546926cc53c2d67262c894f5a86289a | 444 | Pfam | PF06001 | Domain of Unknown Function (DUF902) | 324 | 363 | 7.4E-24 | T | 22-09-2020 | IPR010303 | CREB-binding protein/p300, atypical RING domain |
| UnnamedSample_HQ_transcript/3521|m.1621 | UnnamedSample_HQ_transcript/3521 | Identity 0.880 too low. | 19f7f4fd3d879eced78cc5327d1ac7bc | 982 | Pfam | PF13907 | Domain of unknown function (DUF4208) | 865 | 954 | 1.6E-23 | T | 22-09-2020 | IPR025260 | Domain of unknown function DUF4208 |
| UnnamedSample_HQ_transcript/3521|m.1621 | UnnamedSample_HQ_transcript/3521 | Identity 0.880 too low. | 19f7f4fd3d879eced78cc5327d1ac7bc | 982 | Pfam | PF18375 | CDH1/2 SANT-Helical linker 1 | 558 | 651 | 3.7E-37 | T | 22-09-2020 | IPR040793 | CDH1/2, SANT-Helical linker 1 |
| UnnamedSample_HQ_transcript/3521|m.1621 | UnnamedSample_HQ_transcript/3521 | Identity 0.880 too low. | 19f7f4fd3d879eced78cc5327d1ac7bc | 982 | Pfam | PF00271 | Helicase conserved C-terminal domain | 216 | 328 | 6.5E-20 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/3521|m.1621 | UnnamedSample_HQ_transcript/3521 | Identity 0.880 too low. | 19f7f4fd3d879eced78cc5327d1ac7bc | 982 | Pfam | PF00176 | SNF2 family N-terminal domain | 8 | 189 | 1.1E-42 | T | 22-09-2020 | IPR000330 | SNF2-related, N-terminal domain |
| UnnamedSample_HQ_transcript/29466|m.9346 | UnnamedSample_HQ_transcript/29466 | Coverage 0.141 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00433 | Protein kinase C terminal domain | 617 | 658 | 2.4E-7 | T | 22-09-2020 | IPR017892 | Protein kinase, C-terminal |
| UnnamedSample_HQ_transcript/29466|m.9346 | UnnamedSample_HQ_transcript/29466 | Coverage 0.141 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 41 | 91 | 3.7E-18 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/29466|m.9346 | UnnamedSample_HQ_transcript/29466 | Coverage 0.141 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 106 | 158 | 9.2E-16 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/29466|m.9346 | UnnamedSample_HQ_transcript/29466 | Coverage 0.141 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00069 | Protein kinase domain | 340 | 581 | 6.9E-65 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/29466|m.9346 | UnnamedSample_HQ_transcript/29466 | Coverage 0.141 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00168 | C2 domain | 176 | 280 | 4.1E-27 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/4656|m.2054 | UnnamedSample_HQ_transcript/4656 | Coverage 0.084 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00433 | Protein kinase C terminal domain | 617 | 658 | 2.4E-7 | T | 22-09-2020 | IPR017892 | Protein kinase, C-terminal |
| UnnamedSample_HQ_transcript/4656|m.2054 | UnnamedSample_HQ_transcript/4656 | Coverage 0.084 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 41 | 91 | 3.7E-18 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/4656|m.2054 | UnnamedSample_HQ_transcript/4656 | Coverage 0.084 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 106 | 158 | 9.2E-16 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/4656|m.2054 | UnnamedSample_HQ_transcript/4656 | Coverage 0.084 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00069 | Protein kinase domain | 340 | 581 | 6.9E-65 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/4656|m.2054 | UnnamedSample_HQ_transcript/4656 | Coverage 0.084 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00168 | C2 domain | 176 | 280 | 4.1E-27 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/32849|m.10176 | UnnamedSample_HQ_transcript/32849 | Coverage 0.147 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00433 | Protein kinase C terminal domain | 617 | 658 | 2.4E-7 | T | 22-09-2020 | IPR017892 | Protein kinase, C-terminal |
| UnnamedSample_HQ_transcript/32849|m.10176 | UnnamedSample_HQ_transcript/32849 | Coverage 0.147 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 41 | 91 | 3.7E-18 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/32849|m.10176 | UnnamedSample_HQ_transcript/32849 | Coverage 0.147 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 106 | 158 | 9.2E-16 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/32849|m.10176 | UnnamedSample_HQ_transcript/32849 | Coverage 0.147 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00069 | Protein kinase domain | 340 | 581 | 6.9E-65 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/32849|m.10176 | UnnamedSample_HQ_transcript/32849 | Coverage 0.147 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00168 | C2 domain | 176 | 280 | 4.1E-27 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/39255|m.11702 | UnnamedSample_HQ_transcript/39255 | Coverage 0.159 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00433 | Protein kinase C terminal domain | 617 | 658 | 2.4E-7 | T | 22-09-2020 | IPR017892 | Protein kinase, C-terminal |
| UnnamedSample_HQ_transcript/39255|m.11702 | UnnamedSample_HQ_transcript/39255 | Coverage 0.159 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 41 | 91 | 3.7E-18 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/39255|m.11702 | UnnamedSample_HQ_transcript/39255 | Coverage 0.159 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 106 | 158 | 9.2E-16 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/39255|m.11702 | UnnamedSample_HQ_transcript/39255 | Coverage 0.159 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00069 | Protein kinase domain | 340 | 581 | 6.9E-65 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/39255|m.11702 | UnnamedSample_HQ_transcript/39255 | Coverage 0.159 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00168 | C2 domain | 176 | 280 | 4.1E-27 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/25197|m.8265 | UnnamedSample_HQ_transcript/25197 | Coverage 0.133 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00433 | Protein kinase C terminal domain | 617 | 658 | 2.4E-7 | T | 22-09-2020 | IPR017892 | Protein kinase, C-terminal |
| UnnamedSample_HQ_transcript/25197|m.8265 | UnnamedSample_HQ_transcript/25197 | Coverage 0.133 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 41 | 91 | 3.7E-18 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/25197|m.8265 | UnnamedSample_HQ_transcript/25197 | Coverage 0.133 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 106 | 158 | 9.2E-16 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/25197|m.8265 | UnnamedSample_HQ_transcript/25197 | Coverage 0.133 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00069 | Protein kinase domain | 340 | 581 | 6.9E-65 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/25197|m.8265 | UnnamedSample_HQ_transcript/25197 | Coverage 0.133 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00168 | C2 domain | 176 | 280 | 4.1E-27 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/3678|m.1680 | UnnamedSample_HQ_transcript/3678 | Coverage 0.078 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00433 | Protein kinase C terminal domain | 617 | 658 | 2.4E-7 | T | 22-09-2020 | IPR017892 | Protein kinase, C-terminal |
| UnnamedSample_HQ_transcript/3678|m.1680 | UnnamedSample_HQ_transcript/3678 | Coverage 0.078 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 41 | 91 | 3.7E-18 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/3678|m.1680 | UnnamedSample_HQ_transcript/3678 | Coverage 0.078 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 106 | 158 | 9.2E-16 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/3678|m.1680 | UnnamedSample_HQ_transcript/3678 | Coverage 0.078 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00069 | Protein kinase domain | 340 | 581 | 6.9E-65 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/3678|m.1680 | UnnamedSample_HQ_transcript/3678 | Coverage 0.078 too low. | bec9af1f2d1cc7fb8c3786d6c4cd7ac8 | 667 | Pfam | PF00168 | C2 domain | 176 | 280 | 4.1E-27 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/104273|m.23143 | UnnamedSample_HQ_transcript/104273 | Coverage 0.987 too low. | b996c8a3ab28625b3a00eae46b5c0327 | 246 | Pfam | PF00189 | Ribosomal protein S3, C-terminal domain | 106 | 188 | 1.4E-22 | T | 22-09-2020 | IPR001351 | Ribosomal protein S3, C-terminal |
| UnnamedSample_HQ_transcript/104273|m.23143 | UnnamedSample_HQ_transcript/104273 | Coverage 0.987 too low. | b996c8a3ab28625b3a00eae46b5c0327 | 246 | Pfam | PF07650 | KH domain | 20 | 93 | 5.2E-12 | T | 22-09-2020 | IPR004044 | K Homology domain, type 2 |
| UnnamedSample_HQ_transcript/79029|m.19552 | UnnamedSample_HQ_transcript/79029 | Coverage 0.549 too low. | d0edbdc3d412be310f99b430e9aa1da2 | 396 | Pfam | PF08662 | Eukaryotic translation initiation factor eIF2A | 27 | 222 | 2.4E-78 | T | 22-09-2020 | IPR013979 | Translation initiation factor, beta propellor-like domain |
| UnnamedSample_HQ_transcript/84164|m.20369 | UnnamedSample_HQ_transcript/84164 | Coverage 0.593 too low. | d0edbdc3d412be310f99b430e9aa1da2 | 396 | Pfam | PF08662 | Eukaryotic translation initiation factor eIF2A | 27 | 222 | 2.4E-78 | T | 22-09-2020 | IPR013979 | Translation initiation factor, beta propellor-like domain |
| UnnamedSample_HQ_transcript/30489|m.9582 | UnnamedSample_HQ_transcript/30489 | Coverage 0.615 too low. | 7e02e003e5d98dcd437307deba5fe845 | 816 | Pfam | PF12738 | twin BRCT domain | 143 | 205 | 4.2E-17 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/30489|m.9582 | UnnamedSample_HQ_transcript/30489 | Coverage 0.615 too low. | 7e02e003e5d98dcd437307deba5fe845 | 816 | Pfam | PF00621 | RhoGEF domain | 417 | 598 | 5.1E-41 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
